Rapport Therapeutics Inc

Small-Cap Stocks Pharmaceutical Stocks Healthcare Stocks

$40.45

-1.50 (-3.58%)

As of Sep 20, 10:14 PM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 18 95%

Hold 1 5%

Sell 0 0%

Price Target

Analyst Price Target +11.7% upside

Low Target $32.24

Average Target $45.18

High Target $61.72

Current Price $40.45

Current
$40.45

Target
$45.18

$32.24 $45.18 avg $61.72

Scenario Analysis

Bear Case

$32.24

-20.3%

Low target

Base Case

$45.18

+11.7%

Avg target

Bull Case

$61.72

+52.6%

High target

Risk/Reward

2.6x

Favorable

Price in Context

52-Week High

$52.93

-23.6% from high

52-Week Low

$23.75

+70.3% from low

Target vs 52W High

$45.18

-14.6% vs high

Peer Consensus — Pharmaceuticals

Stock	Consensus	Analysts	Buy %	Target	Upside
LLY Eli Lilly and Co.	Strong Buy	38	79%	$1,330.33	+15.6%
RDY Dr. Reddy's Laboratories	Strong Sell	45	31%	—	+0.0%
JNJ Johnson & Johnson	Buy	31	71%	$299.55	+11.3%
MRK Merck & Co. Inc.	Buy	36	72%	$159.27	+7.6%
PFE Pfizer Inc.	Hold	36	39%	$33.90	+20.3%
BMY Bristol-Myers Squibb Co	Hold	35	43%	$174.50	+185.4%
RPRX Royalty Pharma Plc- Cl A	Strong Buy	16	88%	$36.26	-37.1%
ZTS Zoetis Inc	Hold	24	50%	$209.87	+193.1%